Women Against Lung Cancer
The Roy Castle Lung Cancer Foundation
4-6 Enterprise Way,
Liverpool, Merseyside,
L13 1FB, United Kingdom
Registered Charity:
England & Wales 1046854
Scotland SCO37596
Tel: +44 151 254 7200
Fax: +44 151 254 7273
Email: admin@walcuk.org.uk
Online: Enquiry Form
Patients and Tarceva®
You may have heard about various new drugs being used in the treatment of lung cancer. Here are some of some of the more recently licenced therapies which you may find helpful.
Non small cell lung cancer (NSCLC)
Docetaxel (Taxotere)
Erlotinib (Tarceva)
Gemcitabine (Gemzar)
Paclitaxel (Taxol)
Pemetrexed (Alimta)
Vinorelbine (Navelbine)
Small cell Lung Cancer (SCLC)
Topotecan ( Hycamtin)
Your suitability to any of the above drugs should be discussed with your cancer doctor. The Roy Castle Lung Cancer Foundation does not recommend any particular treatment.
If you feel the need to talk this through with someone please call our Helpline 0800 358 7200 during office hours.